Company Profiles

driven by the PitchBook Platform

gel-e

gel-e
2007 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$3.1M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of advanced wound treatment and hemostatic materials designed to offer a disruptive innovation in the management of human bleeding. The company's wound treatment and hemostatic materials treats battlefield wounds and severe hemorrhage with its user-friendly hemostat which is able to orchestrate the self-assembly of a clot-like seal upon contact with blood, enabling medical institutes to treat bleeding.

Website
Formerly Known As
Remedium Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Therapeutic Devices
Primary Office
387 Technology Drive
Suite 3110B
College Park, MD 20742
United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore gel-e’s full profile, request a free trial.

gel-e Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 13-Jul-2017 $3.1M 00.000 Completed Generating Revenue
6. Seed Round 01-Nov-2016 00.000 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 26-Feb-2014 00000 00000 Completed Generating Revenue
4. Grant 00000 0000 Completed Generating Revenue
3. Grant 18-Jan-2013 00000 0000 Completed Generating Revenue
2. Grant 18-Nov-2011 $150K $75K Completed Startup
1. Early Stage VC 05-Sep-2010 $75K $75K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

gel-e Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

gel-e Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UM Ventures Other Minority 000 0000 000000 0
Robin Hood Ventures Angel Group Minority 000 0000 000000 0
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

gel-e Executive Team (5)

Name Title Board
Seat
Contact
Info
Rich Vincent Chief Financial Officer
Matthew Dowling Ph.D Co-Founder, Chief Scientific Officer & Board Member
Kevin Smith Executive Vice President, Business Development
Srinivasa Raghavan Ph.D Co-Founder & Advisor

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

gel-e Board Members (3)

Name Representing Role Since Contact
Info
Alex Arrow gel-e Board Member 000 0000
Larry Tiffany JD Self Chairman 000 0000
Matthew Dowling Ph.D gel-e Co-Founder, Chief Scientific Officer & Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com